Literature DB >> 19767589

Detection and characterization of NF1 microdeletions by custom high resolution array CGH.

Eric Pasmant1, Audrey Sabbagh, Julien Masliah-Planchon, Véronique Haddad, Marie-José Hamel, Ingrid Laurendeau, Jean Soulier, Béatrice Parfait, Pierre Wolkenstein, Ivan Bièche, Michel Vidaud, Dominique Vidaud.   

Abstract

In 5% to 10% of cases, neurofibromatosis type 1 is caused by microdeletions scattered across the entire NF1 gene and various neighboring genes. The phenotype appears to be more severe in patients with NF1 microdeletions than in patients with NF1 single point mutations. We have developed a new method for detecting and characterizing NF1 microdeletions based on a custom high-resolution oligonucleotide array comparative genomic hybridization by using the custom 8x15K Agilent array format. The array comprised a total of 14,207 oligonucleotide probes spanning the whole of chromosome 17, including 12,314 probes spanning an approximately 8 Mb interval surrounding the NF1 locus. We validated this approach by testing NF1 microdeleted DNA samples previously characterized by means of microsatellites and real-time PCR methods. Our array comparative genomic hybridization provided enough information for subsequent long-range PCR and nucleotide sequencing of the microdeletion endpoints. Unlike previously described methods, our array comparative genomic hybridization was able to unambiguously differentiate between the three types of microdeletions (type I, type II, and atypical) and to characterize atypical microdeletions. Further comparative studies of patients with well-characterized genotypes and phenotypes and different microdeletions sizes and breakpoints will help determine whether haploinsufficiency of deleted genes and/or genes rearrangements influence clinical outcomes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19767589      PMCID: PMC2765750          DOI: 10.2353/jmoldx.2009.090064

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  19 in total

1.  Heterogeneity of breakpoints in non-LCR-mediated large constitutional deletions of the 17q11.2 NF1 tumour suppressor region.

Authors:  H Kehrer-Sawatzki; S Tinschert; D E Jenne
Journal:  J Med Genet       Date:  2003-10       Impact factor: 6.318

2.  Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2.

Authors:  M Venturin; P Guarnieri; F Natacci; M Stabile; R Tenconi; M Clementi; C Hernandez; P Thompson; M Upadhyaya; L Larizza; P Riva
Journal:  J Med Genet       Date:  2004-01       Impact factor: 6.318

3.  Evidence for non-homologous end joining and non-allelic homologous recombination in atypical NF1 microdeletions.

Authors:  Marco Venturin; Cristina Gervasini; Francesca Orzan; Angela Bentivegna; Lucia Corrado; Patrizia Colapietro; Alessandra Friso; Romano Tenconi; Meena Upadhyaya; Lidia Larizza; Paola Riva
Journal:  Hum Genet       Date:  2004-04-21       Impact factor: 4.132

4.  Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients.

Authors:  K Wimmer; S Yao; K Claes; H Kehrer-Sawatzki; S Tinschert; T De Raedt; E Legius; T Callens; H Beiglböck; O Maertens; L Messiaen
Journal:  Genes Chromosomes Cancer       Date:  2006-03       Impact factor: 5.006

5.  The genetic aspects of neurofibromatosis.

Authors:  J C Carey; B J Baty; J P Johnson; T Morrison; M Skolnick; J Kivlin
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

6.  High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene.

Authors:  H Kehrer-Sawatzki; L Kluwe; C Sandig; M Kohn; K Wimmer; U Krammer; A Peyrl; D E Jenne; I Hansmann; V-F Mautner
Journal:  Am J Hum Genet       Date:  2004-07-15       Impact factor: 11.025

7.  Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay.

Authors:  M Upadhyaya; M Ruggieri; J Maynard; M Osborn; C Hartog; S Mudd; M Penttinen; I Cordeiro; M Ponder; B A Ponder; M Krawczak; D N Cooper
Journal:  Hum Genet       Date:  1998-05       Impact factor: 4.132

8.  Characterization of a 7.6-Mb germline deletion encompassing the NF1 locus and about a hundred genes in an NF1 contiguous gene syndrome patient.

Authors:  Eric Pasmant; Aurélie de Saint-Trivier; Ingrid Laurendeau; Anne Dieux-Coeslier; Béatrice Parfait; Michel Vidaud; Dominique Vidaud; Ivan Bièche
Journal:  Eur J Hum Genet       Date:  2008-07-23       Impact factor: 4.246

9.  NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes.

Authors:  P Riva; L Corrado; F Natacci; P Castorina; B L Wu; G H Schneider; M Clementi; R Tenconi; B R Korf; L Larizza
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

10.  Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene.

Authors:  Lan Kluwe; Reiner Siebert; Stefan Gesk; Reinhard E Friedrich; Sigrid Tinschert; Hildegard Kehrer-Sawatzki; Victor-F Mautner
Journal:  Hum Mutat       Date:  2004-02       Impact factor: 4.878

View more
  15 in total

1.  Relevance of MPNST cell lines as models for NF1 associated-tumors.

Authors:  Eric Pasmant; Armelle Luscan; Jennifer Varin; Ingrid Laurendeau; Béatrice Parfait; Dominique Vidaud
Journal:  J Neurooncol       Date:  2013-06-27       Impact factor: 4.130

2.  NF1 single and multi-exons copy number variations in neurofibromatosis type 1.

Authors:  Apolline Imbard; Eric Pasmant; Audrey Sabbagh; Armelle Luscan; Magali Soares; Philippe Goussard; Hélène Blanché; Ingrid Laurendeau; Salah Ferkal; Michel Vidaud; Stéphane Pinson; Christine Bellanne-Chantelot; Dominique Vidaud; Pierre Wolkenstein; Béatrice Parfait
Journal:  J Hum Genet       Date:  2015-01-29       Impact factor: 3.172

3.  First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis.

Authors:  Eric Pasmant; Philippe Goussard; Laetitia Baranes; Ingrid Laurendeau; Samuel Quentin; Philippe Ponsot; Yann Consigny; Olivier Farges; Bertrand Condat; Dominique Vidaud; Michel Vidaud; Jian-Min Chen; Béatrice Parfait
Journal:  Eur J Hum Genet       Date:  2011-10-12       Impact factor: 4.246

4.  A highly sensitive genetic protocol to detect NF1 mutations.

Authors:  María Carmen Valero; Yolanda Martín; Elisabete Hernández-Imaz; Alba Marina Hernández; Germán Meleán; Ana María Valero; Francisco Javier Rodríguez-Álvarez; Dolores Tellería; Concepción Hernández-Chico
Journal:  J Mol Diagn       Date:  2011-03       Impact factor: 5.568

5.  Contribution of whole genome sequencing in the molecular diagnosis of mosaic partial deletion of the NF1 gene in neurofibromatosis type 1.

Authors:  Laurence Pacot; Valerie Pelletier; Albain Chansavang; Audrey Briand-Suleau; Cyril Burin des Roziers; Audrey Coustier; Theodora Maillard; Nicolas Vaucouleur; Lucie Orhant; Cécile Barbance; Alban Lermine; Nadim Hamzaoui; Djihad Hadjadj; Ingrid Laurendeau; Laïla El Khattabi; Juliette Nectoux; Michel Vidaud; Béatrice Parfait; Hélène Dollfus; Eric Pasmant; Dominique Vidaud
Journal:  Hum Genet       Date:  2022-08-09       Impact factor: 5.881

6.  Dissecting the clinical phenotype associated with mosaic type-2 NF1 microdeletions.

Authors:  Hildegard Kehrer-Sawatzki; Julia Vogt; Tanja Mußotter; Lan Kluwe; David N Cooper; Victor-Felix Mautner
Journal:  Neurogenetics       Date:  2012-05-13       Impact factor: 2.660

7.  Evidence-based genomic diagnosis characterized chromosomal and cryptic imbalances in 30 elderly patients with myelodysplastic syndrome and acute myeloid leukemia.

Authors:  Renu Bajaj; Fang Xu; Bixia Xiang; Katherine Wilcox; Autumn J Diadamo; Rachana Kumar; Alexandra Pietraszkiewicz; Stephanie Halene; Peining Li
Journal:  Mol Cytogenet       Date:  2011-01-20       Impact factor: 2.009

8.  Screening for mutation site on the type I neurofibromatosis gene in a family.

Authors:  Ming Lv; Wenhua Zhao; Lin Yan; Liang Chen; Kai Cui; Jie Gao; Fachang Yu; Sheng Li
Journal:  Childs Nerv Syst       Date:  2011-12-30       Impact factor: 1.475

9.  Molecular Characterization of NF1 and Neurofibromatosis Type 1 Genotype-Phenotype Correlations in a Chinese Population.

Authors:  Jia Zhang; Hanxing Tong; Xi'an Fu; Yong Zhang; Jiangbo Liu; Ruhong Cheng; Jianying Liang; Jie Peng; Zhonghui Sun; Hong Liu; Furen Zhang; Weiqi Lu; Ming Li; Zhirong Yao
Journal:  Sci Rep       Date:  2015-06-09       Impact factor: 4.379

10.  Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities.

Authors:  Brigitte Gilbert-Dussardier; Audrey Briand-Suleau; Ingrid Laurendeau; Frédéric Bilan; Hélène Cavé; Alain Verloes; Michel Vidaud; Dominique Vidaud; Eric Pasmant
Journal:  Orphanet J Rare Dis       Date:  2016-07-22       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.